These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 24937180)

  • 1. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.
    Taichman DB; Ornelas J; Chung L; Klinger JR; Lewis S; Mandel J; Palevsky HI; Rich S; Sood N; Rosenzweig EB; Trow TK; Yung R; Elliott CG; Badesch DB
    Chest; 2014 Aug; 146(2):449-475. PubMed ID: 24937180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report.
    Klinger JR; Elliott CG; Levine DJ; Bossone E; Duvall L; Fagan K; Frantsve-Hawley J; Kawut SM; Ryan JJ; Rosenzweig EB; Sederstrom N; Steen VD; Badesch DB
    Chest; 2019 Mar; 155(3):565-586. PubMed ID: 30660783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil.
    Rahaghi FF; Allen RP; Balasubramanian VP; Chakinala MM; Elwing JM; Feldman J; Leary PJ; Rischard F; Safdar Z; Sood N; Oudiz RJ
    Pulm Pharmacol Ther; 2021 Feb; 66():101979. PubMed ID: 33259923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pharmacotherapy options for pulmonary arterial hypertension.
    Perrin S; Chaumais MC; O'Connell C; Amar D; Savale L; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
    Expert Opin Pharmacother; 2015; 16(14):2113-31. PubMed ID: 26290279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents.
    McLaughlin VV; Channick R; De Marco T; Farber HW; Gaine S; Galié N; Krasuski RA; Preston I; Souza R; Coghlan JG; Frantz RP; Hemnes A; Kim NH; Lang IM; Langleben D; Li M; Sitbon O; Tapson V; Frost A
    Chest; 2020 Apr; 157(4):955-965. PubMed ID: 31738929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension.
    Hill NS; Cawley MJ; Heggen-Peay CL
    J Manag Care Spec Pharm; 2016 Mar; 22(3 Suppl A):S3-21. PubMed ID: 27003666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal.
    Sitbon O; Baloira Villar A; Bauer F; Ekmehag B; Gin-Sing W; Jansson K; Kiely DG; Leuchte H; Manes A; Rosenkranz S; Escribano P
    Eur Respir Rev; 2012 Sep; 21(125):259-62. PubMed ID: 22941892
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing expert consensus for the optimal approach to holistic risk-management in pulmonary arterial hypertension: a Delphi process and narrative review.
    Church C; Gin-Sing W; Grady D; Johnson M; Kiely DG; Lordan J; Turner N; Wort SJ; Condliffe R
    Expert Rev Respir Med; 2021 Nov; 15(11):1493-1503. PubMed ID: 34018901
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing response to therapy in idiopathic pulmonary arterial hypertension: a consensus survey of Canadian pulmonary hypertension physicians.
    Borrie AE; Ostrow DN; Levy RD; Swiston JR
    Can Respir J; 2011; 18(4):230-4. PubMed ID: 22059182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for Critical Care Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance.
    Frankel LR; Hsu BS; Yeh TS; Simone S; Agus MSD; Arca MJ; Coss-Bu JA; Fallat ME; Foland J; Gadepalli S; Gayle MO; Harmon LA; Hill V; Joseph CA; Kessel AD; Kissoon N; Moss M; Mysore MR; Papo ME; Rajzer-Wakeham KL; Rice TB; Rosenberg DL; Wakeham MK; Conway EE;
    Pediatr Crit Care Med; 2019 Sep; 20(9):847-887. PubMed ID: 31483379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
    McLaughlin VV; Langer A; Tan M; Clements PJ; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ;
    Chest; 2013 Feb; 143(2):324-332. PubMed ID: 22910999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of pulmonary arterial hypertension.
    Ramani GV; Gill S
    Curr Pharm Des; 2013; 19(22):3963-73. PubMed ID: 23228314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2007 Sep; 15(9):981-1000. PubMed ID: 17719803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.
    Talwar A; Garcia JGN; Tsai H; Moreno M; Lahm T; Zamanian RT; Machado R; Kawut SM; Selej M; Mathai S; D'Anna LH; Sahni S; Rodriquez EJ; Channick R; Fagan K; Gray M; Armstrong J; Rodriguez Lopez J; de Jesus Perez V;
    Am J Respir Crit Care Med; 2017 Oct; 196(8):e32-e47. PubMed ID: 29028375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology for the systematic reviews on an adjacent segment pathology.
    Norvell DC; Dettori JR; Skelly AC; Riew KD; Chapman JR; Anderson PA
    Spine (Phila Pa 1976); 2012 Oct; 37(22 Suppl):S10-7. PubMed ID: 22872224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologies for the development of the management of cough: CHEST guideline and expert panel report.
    Lewis SZ; Diekemper RL; French CT; Gold PM; Irwin RS;
    Chest; 2014 Nov; 146(5):1395-1402. PubMed ID: 25144511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
    Mazzone PJ; Silvestri GA; Patel S; Kanne JP; Kinsinger LS; Wiener RS; Soo Hoo G; Detterbeck FC
    Chest; 2018 Apr; 153(4):954-985. PubMed ID: 29374513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.